Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.71 $1.96 Friday, 10th May 2024 SYBX stock ended at $1.79. This is 2.19% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.23% from a day low at $1.79 to a day high of $1.83.
90 days $1.55 $2.16
52 weeks $0.234 $5.71

Historical Synlogic Inc prices

Date Open High Low Close Volume
Jul 26, 2023 $0.500 $0.515 $0.490 $0.509 143 480
Jul 25, 2023 $0.530 $0.530 $0.498 $0.500 72 015
Jul 24, 2023 $0.500 $0.530 $0.495 $0.529 46 175
Jul 21, 2023 $0.529 $0.551 $0.500 $0.506 145 509
Jul 20, 2023 $0.511 $0.557 $0.510 $0.535 124 061
Jul 19, 2023 $0.500 $0.522 $0.495 $0.522 94 732
Jul 18, 2023 $0.519 $0.530 $0.487 $0.501 227 629
Jul 17, 2023 $0.513 $0.530 $0.493 $0.500 144 475
Jul 14, 2023 $0.512 $0.530 $0.500 $0.504 81 474
Jul 13, 2023 $0.509 $0.540 $0.491 $0.511 200 882
Jul 12, 2023 $0.515 $0.525 $0.475 $0.496 352 168
Jul 11, 2023 $0.528 $0.568 $0.522 $0.530 2 264 007
Jul 10, 2023 $0.522 $0.562 $0.501 $0.502 124 082
Jul 07, 2023 $0.402 $0.540 $0.403 $0.523 580 481
Jul 06, 2023 $0.400 $0.426 $0.400 $0.407 155 052
Jul 05, 2023 $0.408 $0.410 $0.400 $0.409 195 494
Jul 03, 2023 $0.440 $0.440 $0.409 $0.409 159 240
Jun 30, 2023 $0.430 $0.440 $0.417 $0.430 356 117
Jun 29, 2023 $0.424 $0.447 $0.415 $0.440 132 626
Jun 28, 2023 $0.485 $0.522 $0.420 $0.437 275 641
Jun 27, 2023 $0.418 $0.486 $0.410 $0.485 162 228
Jun 26, 2023 $0.470 $0.488 $0.400 $0.419 415 259
Jun 23, 2023 $0.500 $0.500 $0.460 $0.460 282 191
Jun 22, 2023 $0.524 $0.525 $0.500 $0.504 100 736
Jun 21, 2023 $0.545 $0.555 $0.500 $0.520 308 774
Click to get the best stock tips daily for free!

About Synlogic Inc

Synlogic Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed... SYBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT